IRIS
PANICHELLA, GIORGIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.524
NA - Nord America 2.438
AS - Asia 2.271
SA - Sud America 644
AF - Africa 52
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.935
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.279
SG - Singapore 999
IT - Italia 920
RU - Federazione Russa 774
CN - Cina 544
BR - Brasile 536
VN - Vietnam 262
IE - Irlanda 150
DE - Germania 137
GB - Regno Unito 135
NL - Olanda 119
HK - Hong Kong 111
CA - Canada 104
TR - Turchia 61
IN - India 50
FI - Finlandia 48
FR - Francia 47
AR - Argentina 46
PL - Polonia 45
BD - Bangladesh 43
MX - Messico 41
ID - Indonesia 31
IL - Israele 31
PK - Pakistan 30
ES - Italia 27
SE - Svezia 27
EC - Ecuador 24
ZA - Sudafrica 24
AT - Austria 23
JP - Giappone 23
IQ - Iraq 22
CO - Colombia 13
CH - Svizzera 12
MA - Marocco 11
UZ - Uzbekistan 11
LT - Lituania 10
UA - Ucraina 10
AE - Emirati Arabi Uniti 9
BE - Belgio 9
PY - Paraguay 7
SA - Arabia Saudita 7
EG - Egitto 6
RO - Romania 6
CL - Cile 5
KR - Corea 5
PE - Perù 5
VE - Venezuela 5
DK - Danimarca 4
KE - Kenya 4
AL - Albania 3
AU - Australia 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
JO - Giordania 3
KW - Kuwait 3
KZ - Kazakistan 3
NI - Nicaragua 3
UY - Uruguay 3
AM - Armenia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
HN - Honduras 2
IR - Iran 2
LU - Lussemburgo 2
OM - Oman 2
TN - Tunisia 2
AD - Andorra 1
BH - Bahrain 1
CG - Congo 1
CR - Costa Rica 1
CV - Capo Verde 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 7.932
Salva come PNG Salva come JPEG
Città #
Dallas 811
Singapore 535
Beijing 246
Ashburn 239
Dublin 148
Moscow 120
Hong Kong 107
Los Angeles 107
Milan 88
Ho Chi Minh City 85
New York 66
Rome 65
The Dalles 62
Pisa 61
Chandler 60
Hanoi 57
São Paulo 56
Hefei 54
Munich 52
Istanbul 42
Santa Clara 42
Florence 41
Warsaw 39
Montreal 35
London 34
Boardman 30
Beauharnois 29
Lucca 27
Tel Aviv 25
Brooklyn 24
Poplar 24
Boston 23
Chicago 23
Rio de Janeiro 23
Amsterdam 22
Bologna 22
Genoa 22
Stockholm 22
Tokyo 22
Frankfurt am Main 21
Lappeenranta 21
Naples 20
Nuremberg 20
Livorno 19
Orem 19
Brescia 18
Da Nang 18
Mexico City 18
Atlanta 17
Denver 16
Johannesburg 16
Buffalo 15
Chennai 15
Helsinki 15
Mumbai 15
Toronto 15
Turin 15
Belo Horizonte 13
Assago 12
Seattle 12
Turku 12
Washington 12
Manchester 11
Phoenix 11
Redondo Beach 11
Cambridge 10
Charlotte 10
Curitiba 10
Guayaquil 10
Querétaro 10
San Mateo 10
Biên Hòa 9
Brasília 9
Haiphong 9
Houston 9
Lahore 9
Portsmouth 9
Quito 9
San Jose 9
Tashkent 9
Buti 8
Ottawa 8
Palermo 8
Porto Alegre 8
Vienna 8
Zhengzhou 8
Ankara 7
Campinas 7
Cascina 7
Dongguan 7
Jakarta 7
Juiz de Fora 7
Paris 7
Bari 6
Brussels 6
Council Bluffs 6
Dhaka 6
Düsseldorf 6
Guangzhou 6
Padova 6
Totale 4.277
Salva come PNG Salva come JPEG
Nome #
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 445
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 291
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 275
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 233
Screening the health status of people working in a university 215
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 204
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 202
Eligibility for vericiguat in a real‐world, contemporary heart failure population 187
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 185
Role of Imaging in Cardiomyopathies 176
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 173
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 172
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population 169
Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis 167
Subclinical cardiac damage in cancer patients before chemotherapy 167
Valvular heart disease in patients with cardiac amyloidosis 166
RNA-targeting and gene editing therapies for transthyretin amyloidosis 158
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 153
Sex-related differences in ventricular remodeling after myocardial infarction 150
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction 148
The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers 147
Bridging Atrial and Ventricular Failure Through Biomarkers 147
Sex differences in transthyretin cardiac amyloidosis 146
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 146
Assessing cardiac mechanics through left ventricular haemodynamic forces 142
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 142
Pathophysiology of Cardiac Amyloidosis 141
The triglyceride/HDL cholesterol ratio and TyG index predict coronary atherosclerosis and outcome in the general population 141
Cardiac Amyloidosis: How Its Epidemiology is Changing 138
Management and treatment of cardiotoxicity due to anticancer drugs: 10 questions and answers 133
Characteristics of patients with suspected cardiac amyloidosis in Tuscany and Umbria: Insights from the cardiac amyloidosis RegistRY (CARRY) 131
Pathophysiological Rationale and Clinical Evidence for Neurohormonal Modulation in Heart Failure with Preserved Ejection Fraction 128
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 126
Shared and unique characteristics of metabolic syndrome in psychotic disorders: a review 125
Heart failure with preserved ejection fraction risk after aortic coarctation surgery: The hidden threat 121
Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin 117
Indications of beta-adrenoceptor blockers in Takotsubo syndrome and theoretical reasons to prefer agents with vasodilating activity 117
Current and emerging treatment options for transthyretin amyloid cardiomyopathy 115
Gamma-glutamyltransferase independently predicts mortality and hospitalization for heart failure in cardiac transthyretin amyloidosis 111
Echocardiographic Estimate of Pulmonary Capillary Wedge Pressure Improves Outcome Prediction in Heart Failure Patients with Reduced and Mildly Reduced Ejection Fraction 110
High-sensitivity troponins for outcome prediction in the general population: a systematic review and meta-analysis 109
Tetrameric Transthyretin as a Protective Factor Against Alzheimer’s Disease 108
Dissecting the heart failure phenotype through phenomics 107
CRISPR-Cas9 for the Treatment of Transthyretin Cardiac Amyloidosis 103
Pirfenidone as a novel cardiac protective treatment 99
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 97
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 91
The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism 91
Heart Failure Management in Cardiac Amyloidosis: Towards a Paradigm Shift 87
Identifying reliable biomarkers for pulmonary congestion: Toward a close yet sustainable heart failure follow‐up 80
Transesophageal Echocardiography Before Elective Direct Current Cardioversion in Cardiac Amyloidosis: Too Soon to Discard It? 79
Insulin‐like growth factor binding protein‐7 in heart failure: The challenge of moving from risk prediction to a biomarker‐guided management 79
Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond 78
Metabolomics to predict heart failure development: A new frontier? 76
null 29
Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin Cardiomyopathy 24
Totale 7.997
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.681
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202266 0 0 0 5 7 7 10 17 7 6 2 5
2022/2023367 5 28 10 21 44 40 14 47 109 10 27 12
2023/2024333 13 11 63 36 7 25 27 13 15 26 28 69
2024/20252.806 71 68 134 108 184 154 383 539 286 175 378 326
2025/20264.425 441 1.077 771 1.145 801 190 0 0 0 0 0 0
Totale 7.997